Results 241 to 250 of about 241,974 (292)

Transcriptomic Changes Underlying the Anti-Steatotic Effects of DHA Supplementation in Aged Obese Female Mice. [PDF]

Int J Mol Sci
Pejenaute Martínez de Lizarrondo Á, Martín-Climent P, Martínez-Rubio M, Saborido-Gavilán J, Sáinz N, Félix-Soriano E, Samblas M, Alfonso-Núñez M, Guruceaga E, Lostao MP, González-Muniesa P, Moreno-Aliaga MJ.   +11 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Evaluation of leptin treatment on maintenance of body weight loss in diet-induced obese mice. [PDF]

Diabetes Obes Metab
Breen DM, Saavedra-Peña RM, Joaquim S, Kong J, Reese R, Kuzmiski JB, Stansfield JC, Jones R, Bence KK, Jackson VM.   +9 more
europepmc   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Gut microbiota composition combined with reduced intestinal fatty acid uptake prevents hepatic steatosis in obesity-resistant mice fed a high-fat diet. [PDF]

Sci Rep
Vratarić M, Teofilović A, Vojnović Milutinović D, Veličković N, Đmura G, Djordjevic A.   +5 more
europepmc   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Molecular mechanisms linking adipose tissue-derived small extracellular vesicles/exosomes to the development or amelioration of obesity, insulin resistance, and diabetes-related complications. [PDF]

Eur J Med Res
Chen L, Amraee F, Sadegh-Nejadi S, Saberian M, Ghahari SA, Miao X, Lisco G, Afrisham R.   +7 more
europepmc   +1 more source

Anti-Obesity Effects Exerted by <i>Achyranthes bidentata</i> Polysaccharides in Diet-Induced Obese Mice. [PDF]

Food Sci Nutr
Li SN, Zhang WK, Liu YM, Shi W, Zhang YC, Li XY, Jin LA, Cui MJ, Li YR, Chen WB.   +9 more
europepmc   +1 more source

The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer. [PDF]

Ann Med
Zhang H, Wang Y, Ning B, Wang Y, Sun T, Xu J.   +5 more
europepmc   +1 more source